1. Xu, Yan, Sun, Fang, Tian, Yuying, Yang, Penghui, Liu, Rong. 2024. Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma. In International immunopharmacology, 129, 111628. doi:10.1016/j.intimp.2024.111628. https://pubmed.ncbi.nlm.nih.gov/38320351/
2. Aydemir, Esra, Tüysüz, Emre Can, Bayrak, Ömer Faruk, Hızlı-Deniz, Ayşen Aslı, Şahin, Fikrettin. 2023. Impact of silencing eEF2K expression on the malignant properties of chordoma. In Molecular biology reports, 50, 3011-3022. doi:10.1007/s11033-023-08257-z. https://pubmed.ncbi.nlm.nih.gov/36652154/
3. Jana, Sujata, Brahma, Sandipan, Arora, Sonali, Henikoff, Steven, Hsieh, Andrew C. 2023. Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression. In Cancer cell, 41, 853-870.e13. doi:10.1016/j.ccell.2023.03.021. https://pubmed.ncbi.nlm.nih.gov/37084735/
4. Li, Weifen, Ali, Tahir, Zheng, Chengyou, Yu, Zhi-Jian, Li, Shupeng. 2021. Fluoxetine regulates eEF2 activity (phosphorylation) via HDAC1 inhibitory mechanism in an LPS-induced mouse model of depression. In Journal of neuroinflammation, 18, 38. doi:10.1186/s12974-021-02091-5. https://pubmed.ncbi.nlm.nih.gov/33526073/
5. Karakas, Didem, Ozpolat, Bulent. 2020. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. In Journal of molecular medicine (Berlin, Germany), 98, 775-787. doi:10.1007/s00109-020-01917-8. https://pubmed.ncbi.nlm.nih.gov/32377852/
6. Jiang, Mingxia, Qi, Ling, Jin, Kexin, Li, Yanjing, Song, Chengxin. 2021. eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients. In Pathology, research and practice, 225, 153568. doi:10.1016/j.prp.2021.153568. https://pubmed.ncbi.nlm.nih.gov/34352439/
7. Wang, Nan, Cen, Li-Lan, Tian, Zhe, Long, Xi-Dai, Yang, Qian. 2024. eEF2K as an important kinase associated with cancer survival and prognosis. In Scientific reports, 14, 29284. doi:10.1038/s41598-024-78652-4. https://pubmed.ncbi.nlm.nih.gov/39592671/
8. Fu, L L, Xie, T, Zhang, S Y, Liu, B. . Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer. In Apoptosis : an international journal on programmed cell death, 19, 1527-31. doi:10.1007/s10495-014-1019-7. https://pubmed.ncbi.nlm.nih.gov/25023961/
9. Beretta, Stefania, Gritti, Laura, Ponzoni, Luisa, Verpelli, Chiara, Sala, Carlo. 2022. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K). In Molecular autism, 13, 1. doi:10.1186/s13229-021-00484-0. https://pubmed.ncbi.nlm.nih.gov/34980259/
10. Taha, Elham, Patil, Sudarshan, Barrera, Iliana, Bramham, Clive R, Rosenblum, Kobi. 2020. eEF2/eEF2K Pathway in the Mature Dentate Gyrus Determines Neurogenesis Level and Cognition. In Current biology : CB, 30, 3507-3521.e7. doi:10.1016/j.cub.2020.06.061. https://pubmed.ncbi.nlm.nih.gov/32707059/
智鼠故事 
